Reuters logo
BRIEF-Progenics Pharmaceuticals announces positive topline results from registrational Phase 2B trial of Azedra®
2017年3月30日 / 上午10点17分 / 6 个月前

BRIEF-Progenics Pharmaceuticals announces positive topline results from registrational Phase 2B trial of Azedra®

March 30 (Reuters) - Progenics Pharmaceuticals Inc

* Progenics Pharmaceuticals announces positive topline results from registrational phase 2b trial of azedra®

* Progenics Pharmaceuticals Inc - study achieves primary endpoint

* Progenics Pharmaceuticals Inc - secondary endpoint shows favorable tumor response to therapy

* Progenics Pharmaceuticals Inc - company to submit nda in mid-2017 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below